KADENSA CAPITAL Ltd Purchases Shares of 458,745 Tempus AI, Inc. $TEM

Key Points

• KADENSA CAPITAL Ltd invested $22.13 million to acquire 458,745 shares in Tempus AI, making it the firm's 7th largest position at 2.7% of their portfolio.
• Several institutional investors significantly increased their stakes in Tempus AI, with Advisors Asset Management raising theirs by 753.9% during the first quarter.
• Analysts generally have a positive outlook on Tempus AI, with an average price target of $69.50, and notable upgrades from firms like Morgan Stanley and Bank of America.

KADENSA CAPITAL Ltd acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 458,745 shares of the company's stock, valued at approximately $22,130,000. Tempus AI accounts for 2.7% of KADENSA CAPITAL Ltd's portfolio, making the stock its 7th largest holding. KADENSA CAPITAL Ltd owned 0.27% of Tempus AI as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. ARK Investment Management LLC grew its holdings in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after buying an additional 1,981,755 shares in the last quarter. Vanguard Group Inc. grew its holdings in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after buying an additional 5,900,668 shares in the last quarter. Nikko Asset Management Americas Inc. grew its holdings in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after buying an additional 1,021,460 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, Frontier Capital Management Co. LLC increased its position in shares of Tempus AI by 236.2% in the fourth quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company's stock worth $31,860,000 after purchasing an additional 663,018 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CFO James William Rogers sold 7,528 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares in the company, valued at $10,337,009.45. The trade was a 5.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erik Phelps sold 3,664 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the transaction, the executive vice president directly owned 94,115 shares in the company, valued at approximately $7,025,684.75. This represents a 3.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,108,951 shares of company stock worth $77,660,938. 26.27% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research analyst reports. Morgan Stanley upped their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Guggenheim lifted their price target on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Needham & Company LLC reissued a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Bank of America lifted their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Finally, Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $69.50.

Tempus AI Trading Up 1.9%

TEM stock traded up $1.50 on Friday, reaching $79.62. The company's stock had a trading volume of 8,986,670 shares, compared to its average volume of 11,938,277. The business has a fifty day simple moving average of $65.39 and a two-hundred day simple moving average of $59.04. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $91.45. The firm has a market cap of $13.83 billion, a PE ratio of -66.91 and a beta of 5.08. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. During the same quarter in the prior year, the company earned ($6.86) earnings per share. The firm's quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.